FERMT3 Gene Leukocyte adhesion deficiency type 3 Genetic Test
Test Name: FERMT3 Gene Leukocyte adhesion deficiency type 3 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Hematology
Doctor: Hematologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for FERMT3 Gene Leukocyte adhesion deficiency type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FERMT3 Gene Leukocyte adhesion deficiency type 3 NGS Genetic DNA Test gene FERMT3
Test Details
The FERMT3 gene is associated with a condition called leukocyte adhesion deficiency type 3 (LAD3). LAD3 is a rare genetic disorder that affects the immune system. It is characterized by impaired adhesion and migration of white blood cells, which leads to recurrent infections, delayed wound healing, and other immune-related problems.
NGS (Next-Generation Sequencing) genetic testing refers to a method used to analyze and sequence a person’s DNA. It allows for the simultaneous analysis of multiple genes, including the FERMT3 gene, to identify any genetic variations or mutations that may be associated with LAD3. This type of testing can help diagnose individuals with suspected LAD3 and provide information about their genetic risk for the condition.
NGS genetic testing for FERMT3 gene mutations can be helpful in confirming a diagnosis of LAD3 and guiding treatment decisions. It can also be used for carrier testing in families with a history of LAD3, allowing individuals to determine their risk of passing the condition on to their children.
It is important to note that genetic testing should be conducted under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and support.
| Test Name | FERMT3 Gene Leukocyte adhesion deficiency type 3 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hematology |
| Doctor | Hematologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for FERMT3 Gene Leukocyte adhesion deficiency type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FERMT3 Gene Leukocyte adhesion deficiency type 3 NGS Genetic DNA Test gene FERMT3 |
| Test Details |
The FERMT3 gene is associated with a condition called leukocyte adhesion deficiency type 3 (LAD3). LAD3 is a rare genetic disorder that affects the immune system. It is characterized by impaired adhesion and migration of white blood cells, which leads to recurrent infections, delayed wound healing, and other immune-related problems. NGS (Next-Generation Sequencing) genetic testing refers to a method used to analyze and sequence a person’s DNA. It allows for the simultaneous analysis of multiple genes, including the FERMT3 gene, to identify any genetic variations or mutations that may be associated with LAD3. This type of testing can help diagnose individuals with suspected LAD3 and provide information about their genetic risk for the condition. NGS genetic testing for FERMT3 gene mutations can be helpful in confirming a diagnosis of LAD3 and guiding treatment decisions. It can also be used for carrier testing in families with a history of LAD3, allowing individuals to determine their risk of passing the condition on to their children. It is important to note that genetic testing should be conducted under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and support. |
